title: Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium.
abstract: The effects of oral administration of bovine lactoferrin (bLF) and its hydrolysate on the lung colonization by colon 26 carcinoma were investigated. At doses of 100 or 300 mg/kg/day for seven successive days, bLFs demonstrated a significant inhibitory effect on experimental metastasis, which indicated effectiveness before and after tumor implantation. Oral administration of bLFs augmented CD4+, CD8+, and asialoGM1+ cells in the spleen and peripheral blood. Their cytotoxic activities against Yac-1 and colon 26 carcinoma were enhanced by bLF. In the small intestinal epithelium, CD4+ and CD8+ cells were markedly increased, and, simultaneously, enhanced production of interleukin-18 (IL-18) was confirmed in the intestinal epithelial cells. In this model, intravenous injection of murine IL-18 showed significant inhibition of the lung colonization by colon 26 carcinoma. These results suggested that inhibition of experimental metastasis by oral administration of bLF and pepsin hydrolysate of bLF might be due to enhanced cellular immunity, presumably mediated by enhanced IL-18 production in the intestinal epithelium.
authors.affiliation: Experimental Pathology and Chemotherapy Division, National Cancer Research Institute, Tokyo, Japan. t_kuhara@morinagamilk.co.jp
authors.forename: T
authors.initials: T
authors.lastname: Kuhara
authors.forename: M
authors.initials: M
authors.lastname: Iigo
authors.forename: T
authors.initials: T
authors.lastname: Itoh
authors.forename: Y
authors.initials: Y
authors.lastname: Ushida
authors.forename: K
authors.initials: K
authors.lastname: Sekine
authors.forename: N
authors.initials: N
authors.lastname: Terada
authors.forename: H
authors.initials: H
authors.lastname: Okamura
authors.forename: H
authors.initials: H
authors.lastname: Tsuda
mesh_terms: D000284:Administration, Oral; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002277:Carcinoma / Q000473:pathology / Q000517:prevention & control / Q000556:secondary; D003110:Colonic Neoplasms / Q000473:pathology; D005455:Fluorescent Antibody Technique; D005677:G(M1) Ganglioside / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular; D020382:Interleukin-18 / Q000096:biosynthesis* / Q000276:immunology; D007413:Intestinal Mucosa / Q000187:drug effects / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D007781:Lactoferrin / Q000008:administration & dosage* / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology / Q000517:prevention & control* / Q000556:secondary*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D013047:Specific Pathogen-Free Organisms; D013154:Spleen / Q000166:cytology; D014407:Tumor Cells, Cultured
chemical_list: D020382:Interleukin-18; D005677:G(M1) Ganglioside; C018835:asialo GM1 ganglioside; D007781:Lactoferrin